Advisor Group Holdings, Inc. Immuno Gen, Inc. Transaction History

Advisor Group Holdings, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$12.46 - $29.95 $158,092 - $380,005	-12,688 Reduced 20.92%	47,950 $1.42 Million
Q3 2023 Nov 13, 2023	BUY	$14.09 - $19.87 $132,953 - $187,493	9,436 Added 18.43%	60,638 $962,000
Q2 2023 Aug 10, 2023	SELL	$3.75 - $20.05 $46,680 - $249,582	-12,448 Reduced 19.56%	51,202 $966,000
Q1 2023 May 12, 2023	SELL	$3.67 - $4.92 $15,641 - $20,969	-4,262 Reduced 6.28%	63,650 $244,000
Q4 2022 Feb 10, 2023	SELL	$4.55 - $6.31 $48,844 - $67,737	-10,735 Reduced 13.65%	67,912 $336,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $8,910 - $12,868	-1,989 Reduced 2.47%	78,647 $375,000
Q2 2022 Aug 10, 2022	SELL	$3.15 - $5.76 $26,431 - $48,332	-8,391 Reduced 9.43%	80,636 $363,000
Q1 2022 May 04, 2022	BUY	$4.26 - $7.48 $9,538 - $16,747	2,239 Added 2.58%	89,027 $527,000
Q3 2021 Nov 05, 2021	SELL	$5.02 - $6.59 $7,615 - $9,997	-1,517 Reduced 1.72%	86,788 $492,000
Q2 2021 Aug 02, 2021	SELL	$5.79 - $8.6 $20,849 - $30,968	-3,601 Reduced 3.92%	88,305 $581,000
Q1 2021 May 13, 2021	SELL	$6.5 - $10.53 $1,274 - $2,063	-196 Reduced 0.21%	91,906 $745,000
Q4 2020 Feb 10, 2021	SELL	$3.7 - $7.66 $21,663 - $44,849	-5,855 Reduced 5.98%	92,102 $593,000
Q3 2020 Nov 12, 2020	BUY	$3.45 - $4.89 $3,826 - $5,423	1,109 Added 1.15%	97,957 $353,000
Q2 2020 Aug 14, 2020	BUY	$3.32 - $5.34 $5,703 - $9,174	1,718 Added 1.81%	96,848 $445,000
Q1 2020 May 18, 2020	BUY	$2.12 - $6.8 $201,675 - $646,884	95,130 New	95,130 $325,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.